Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - OTHER LONG-TERM ASSETS
Other Long-term Assets ALNY - Alnylam Pharmaceuticals, Inc.
134 M
LAST VALUE
7.68%
2 YEAR CAGR
0.00%
5 YEAR CAGR
-7.11%
10 YEAR CAGR